Sree Rayalaseema Hi-Strength Hypo Ltd - Valuation Update

Sree Rayalaseema Hi-Strength Hypo Ltd closes   at ₹ 97.80   with  a  Loss     of   -0.60 %   on    15-May- 2020   with formation of  a  Small Red  Candle    on Daily  Price Chart.

The company has posted Net Sales of Rs.706 Cr and Net Profit of Rs.9.00 Cr during the past 4Quaters ( March-Dec 2019).

At CMP  it’s trading  at X 1.2 of its Valuations ( ~20 Premium ) with   Margin of Safety (1Yr Bond Yield: Value>1 ) 1.30. Its Growth Candidate ( If >1 ) is 1.03, which makes it Attractive.

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source | NSE Website | Screener.In  | Capital Line | Money Control | SMC Global |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

Kaveri Seed Company Ltd - Valuation Update & Price Tag

Kaveri Seed Company Ltd closes   at ₹ 376.45   with  a  Gain     of   +1.60 %   on    15-May- 2020   with formation of  a  Small Green  Candle    on Daily  Price Chart.

The company is expected to post  Revenue of Rs.885.90 Cr & Net Profit of Rs.242.70Cr (Last Year  Revenue of Rs.809.40 Cr & Net Profit of Rs.217.4 Cr  FY2019)  in FY2020 and Revenue of Rs.718.60 Cr & Net Profit of Rs.160.70 Cr in FY2021;  Revenue of Rs.913.80 Cr & Net Profit of Rs.252.90 Cr in FY2022 and Revenue of Rs.960.20 Cr & Net Profit of Rs.264.00 Cr in FY2023.

At CMP  it’s trading with   Margin of Safety (1Yr Bond Yield: Value>1 ) of 2.70.

Valuations  : The Company is now Trading at X0.6 of its Value ( last 4 Quarters earnings considered ) . We have valued the company with its full  Financial  year 2020 earnings  ( PAT ), which is now X0.57, a  Discount  of ~43 % to its Value ( EPV Method ) and X0.86 of its FY21 earnings with a Discount of ~14% ; X0.55 of its FY22 earnings with a Discount of ~45% and X0.52  of its FY23 earnings with a Discount of ~48%

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source | NSE Website | Screener.In  | Capital Line | Money Control | SMC Global |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |

Ipca Laboratories Ltd - Valuation Update & Price Movement

Ipca Laboratories Ltd  closes   at ₹ 1531.90  with  a  Gain     of    +0.2 %   on    08-May- 2020   with formation of  a  Green  Candle    on Daily  Price Chart.

The company is expected to post  Revenue of Rs.4472.45 cr & Net Profit of Rs.656.68 Cr (Last Year  Revenue of Rs.3773.18 Cr & Net Profit of Rs.444.83 Cr  FY2019)  in FY2020 and Revenue of Rs.5093.11 cr & Net Profit of Rs.787.77Cr in FY2021.

At CMP  it is  at Premium  in EV/EBITDA to 10 Yrs Avg by ~33%

Valuations  : The Company is now Trading at X2.8 of its Value ( last 4 Quarters earnings considered )  .We have valued the company with its full  Current year 2020 earnings  ( PAT ), which is now X2.07, a  premium  of ~207% to its Value ( EPV Method ) and X1.49 of its CY21 earnings with a Premium of ~49% to its Value.

Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #   https://t.me/TheNiftyNext

Data Source | NSE Website | Screener.In  | Capital Line | Money Control | SMC Global |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext   |